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Xenogeneic T -Cell-Mediated Immune Reactivity in the Model of 
Pig-to-Humans: First Findings With Native Stimulator Cells 
K. Ulrichs, V. Eckstein, and W. MOller-Ruchholtz 
COMPARED with the humoral response in xenotrans-plantation, which is dominated by preformed natural 
and graft-induced xenophile antibodies, and which repre-
sents the primary barrier to successful transplantation, 
much less is known about the cell-mediated xenogeneic 
immune response. Two suggestions have caused confusion 
rather than clarity: (1) the cell-mediated response is either 
low or even lacking, because co stimulatory cell surface 
molecules on stimulator and responder cells are incompat-
ible and because humoral co stimulating factors are species 
specific,! and (2) the response is significantly lower than 
the allogeneic response because xenoantigens are exclu-
sively presented via the indirect pathway by the host's 
antigen-presenting cells (APC). 2 However, there is a single 
report documenting direct xenoantigen presentation to 
human CD4+ T cells, including porcine, rabbit, monkey, 
dog, and rat antigens, but excluding mouse antigens.3 The 
aim of this study is the evaluation of the capability of 
porcine MHC class 11+ APC to directly trigger a T-cell-
mediated xenogeneic immune response in the potential 
future recipient of porcine donor organs, the human pa-
tient. 
MATERIALS AND METHODS 
Preparation of Peripheral Blood lymphocytes (PBl) That 
Serve as Responders and Stimulators in the Mixed 
lymphocyte Culture (MlC) 
Human PBL. Heparinized vein blood was obtained from two 
healthy, HLA-typed human volunteers, HI (man, 35 years) and 
H2 (woman, 40 years). PBL were prepared by density gradient 
centrifugation according to a standard protocol and adjusted to a 
final concentration of 5 x 104 cells/mL RPM! supplemented with 
10% heat-inactivated human AB serum. These cells served as 
responders (unseparated and separated: see below) in the xeno-
geneic and the allogeneic MLC, and also as stimuIators in the 
allogeneic MLC. StimuIator cells were irradiated with 25 G. 
Porcine PBL. Heparinized porcine blood was collected from 
pigs at a local slaughterhouse during the slaughtering process 
under semisteriIe conditions. PBL were prepared from whole 
blood according to the protocol for human cells (see above). The 
final cell concentration was 5 x 104 cells/mL RPM! supplemented 
with 10% heat-inactivated human AB serum. These cells served 
as stimulators (unseparated and separated: see below) in the MLC 
and were therefore irradiated with 25 G. 
Xenogeneic MLC. The xenogeneic MLC consisted of two 
experiments, HI-anti-pig and H2-anti-pig. The MLC (coincuba-
tion of 5 x 10"' responders and 5 x 104 irradiated stimulators) 
lasted for 6 days (37°C, 5% CO2 in air, humidified). Cell prolifer-
ation was measured by 3H-thymidine incorporation during the last 
16 hours of the culture period. 
Allogeneic MLC. The allogeneic MLC, HI-anti-H2 and H2-
anti-HI, served as allogeneic control and proliferation reference. 
The combination was mismatched at one A locus, two B loci, and 
one DR locus. The number of responder and stimulator cells, 
culture time, and 3H-thymidine uptake were otherwise identical to 
the xenogeneic experiment. 
Cell Separation Procedure. To determine the pathway of anti-
gen recognition or antigen presentation (direct vs indirect), re-
sponder and stimuJator cells were separated from potential APC. 
Human T cells were prepared from PBL by separating B lympho-
cytes (incubation with anti-CDl9 monoclonal antibody [MAb] , 
Dianova, Hamburg, Germany) and monocytes (anti-CDI4 MAb, 
Dianova) with the help of magnetic, secondary antibody-coupled 
dynabeads (Dynal, Oslo, Norway). APC-free porcine T cells were 
prepared from PBL by separating the monocytes/macrophages 
with the mouse anti-pig MAb, 74-22-15A, (ATCC, RockviIIe, Md) 
and coupling them to dynabeads (see above), leaving B cells 
unaffected. They did not act as APC because of the purification 
control experiment: human T-anti-porcine T gave negative prolif-
eration results. The quality of the cell separation, whether human 
or porcine, was additionally controlled by the indirect immuno-
fluorescence binding assay using flow cytometry (F ACScan, Bec-
ton Dickinson, Heidelberg, Germany). Human responder T cells 
and porcine stimulator T cells were used in coculture experiments 
when APC contamination was 0.09% or less. 
RESULTS 
The results of this study investigating the cell-mediated 
xenogeneic immune response in the clinically relevant 
combination human anti-pig are documented in Fig I. The 
results for HI-anti-pig are shown in the top part of the 
figure and the results for H2-anti-pig in the bottom part. 
The main findings are: (1) When unseparated human 
responder PBL are cocultured with unseparated, irradi-
ated native porcine stimulator PBL in the xenogeneic 
MLC, the human T cells show a significant cell-mediated 
immune response against porcine antigens. This holds for 
both responders, HI and H2 (experiment 2). In both cases 
the xenogeneic responses are similar in strength to the 
allogeneic MLC control responses (experiment 1). (2) 
When purified human T cells serve as responders to 
nonpurified porcine stimulator cells, thus analyzing the 
direct pathway of antigen presentation and eliminating the ' 
indirect pathway, different results are observed with the 
two human responders: (a) a significantly reduced re-
sponse with responder HI (experiment 3, top), indicating a 
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Fig 1. Xeno~eneic T-cell-mediated immune reactivity in the 
model pig-to-human. Xenogeneic MLC with human PBL as re-
sponders and irradiated native porcine PBL as stimulator cells. 
The top part of the figure shows the proliferation results with 
human responder H1. the bottom part the results with human 
responder H2. Experiment 1: Allogeneic control response H1-
anti-H2 (top) and H2-anti-H1 (bottom). Experiment 2: Xenogeneic 
response H1-anti-pig (top) and H2-anti-pig (bottom) using unsep-
arated human and porcine PBL. Experiment 3: As in experiment 2. 
but with APC-free. purified human responder T cells (minus 
CD14+ monocytes and CD19+ B Iymphocytes) to analyze direct 
antigen presentation. Experiment 4: As it, experiment 2. but with 
APC-free. purified porcine stimulator T cells (minus 74-22-15A+ 
monocytes) to analyze indirect antigen presentation. Experiment 
5: A combination of experiments 3 and 4. to functionally confirm 
that the purification status of responder T and stimulator T cells is 
satisfactory . 
partial lack of direct presentation and (b) the full response 
with responder H2 (experiment 3, bottom), indicating 
direct presentation only. (3) When purified porcine T cells, 
which were shown to be incapable of stimulating human 
responder T cells in a control assay (experiment 5), were 
cocultured with human PBL, thus excluding direct presen-
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tation, the results obtained with the two human responders 
differed again: (a) a moderate but significant response was 
obtained with responder HI (experiment 4, top), indicating 
indirect antigen presentation, and (b) a completely nega-
tive response with responder H2 (experiment 4, bottom), 
indicating the lack of indirect antigen presentation by this 
responder's APe. These reaction patterns have been con-
firmed with other human responders (data not shown). 
DISCUSSION 
This report deals with work still in progress. The main 
finding, a significant difference in the responsiveness of 
human T cells against porcine antigens, has been con-
firmed with several individuals in each T -cell-mediated 
reaction pattern group. The reason why human T cells 
recognize porcine antigens either entirely directly or in a 
mixed fashion, that is, directly and indirectly, is not yet 
understood and will be further evaluated. If the two 
reaction patterns in Fig I could be confirmed with a larger 
number of human responders, this would definitely have 
consequences for the necessity of manipulating xenograft 
immunogenicity prior to transplantation. 
It appears to be clear at this point that an allogeneic 
T -cell-mediated response is much easier to induce than the 
xenogeneic response human anti-pig. This may be con-
cluded from cell separation experiments with insufficiently 
purified T cells. Whereas such a batch of human responder 
T cells was still capable of eliciting a significant immune 
response against sufficiently purified allogeneic T-stimula-
tor cells (controlled by FACS) , they were incapable of 
eliciting a response against sufficiently purified porcine T 
cells (data not shown). However, ifaxenogeneic response 
was inducible, its magnitUde was similar to the allogeneic 
response. While we were preparing this manuscript, our 
findings were confirmed by other authors.4 The basic 
findings here and there are comparable: a strong xenoge-
neic response human anti-pig that more or less equals the 
human allogeneic response. As our understanding of the 
basic mechanisms of cellular immunity in this xenogeneic 
combination with its clinical potential grows, the time may 
not be too far away that porcine tissue will help to solve 
the problem of human donor organ shortage. 
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